Annual FCF
-$39.96 M
+$2.02 M+4.80%
31 December 2023
Summary:
Cue Biopharma annual free cash flow is currently -$39.96 million, with the most recent change of +$2.02 million (+4.80%) on 31 December 2023. During the last 3 years, it has fallen by -$6.87 million (-20.77%). CUE annual FCF is now -1556.83% below its all-time high of -$2.41 million, reached on 31 December 2015.CUE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$7.53 M
+$2.47 M+24.74%
30 September 2024
Summary:
Cue Biopharma quarterly free cash flow is currently -$7.53 million, with the most recent change of +$2.47 million (+24.74%) on 30 September 2024. Over the past year, it has increased by +$273.00 thousand (+3.50%). CUE quarterly FCF is now -303.67% below its all-time high of -$1.86 million, reached on 31 December 2017.CUE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$38.32 M
+$273.00 K+0.71%
30 September 2024
Summary:
Cue Biopharma TTM free cash flow is currently -$38.32 million, with the most recent change of +$273.00 thousand (+0.71%) on 30 September 2024. Over the past year, it has increased by +$1.20 million (+3.02%). CUE TTM FCF is now -853.31% below its all-time high of -$4.02 million, reached on 31 March 2017.CUE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CUE Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.8% | +3.5% | +3.0% |
| 3 y3 years | -20.8% | -13.3% | -5.8% |
| 5 y5 years | -41.4% | +18.4% | -34.9% |
CUE Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -20.8% | +4.8% | -13.3% | +41.7% | -5.8% | +9.0% |
| 5 y | 5 years | -41.4% | +4.8% | -16.7% | +41.7% | -34.9% | +9.0% |
| alltime | all time | -1556.8% | +4.8% | -303.7% | +41.7% | -853.3% | +9.0% |
Cue Biopharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.53 M(-24.7%) | -$38.32 M(-0.7%) |
| June 2024 | - | -$10.00 M(+1.6%) | -$38.60 M(-1.0%) |
| Mar 2024 | - | -$9.84 M(-10.2%) | -$38.97 M(-2.5%) |
| Dec 2023 | -$39.96 M(-4.8%) | -$10.96 M(+40.5%) | -$39.96 M(+1.1%) |
| Sept 2023 | - | -$7.80 M(-24.8%) | -$39.52 M(+2.2%) |
| June 2023 | - | -$10.37 M(-4.3%) | -$38.67 M(-6.2%) |
| Mar 2023 | - | -$10.83 M(+3.0%) | -$41.21 M(-1.8%) |
| Dec 2022 | -$41.98 M(+5.6%) | -$10.52 M(+51.3%) | -$41.98 M(-0.3%) |
| Sept 2022 | - | -$6.95 M(-46.2%) | -$42.11 M(+0.7%) |
| June 2022 | - | -$12.91 M(+11.3%) | -$41.80 M(+7.4%) |
| Mar 2022 | - | -$11.60 M(+9.0%) | -$38.91 M(-2.1%) |
| Dec 2021 | -$39.75 M(+20.1%) | -$10.65 M(+60.3%) | -$39.75 M(+9.8%) |
| Sept 2021 | - | -$6.64 M(-33.7%) | -$36.21 M(-3.7%) |
| June 2021 | - | -$10.02 M(-19.5%) | -$37.61 M(+8.7%) |
| Mar 2021 | - | -$12.44 M(+75.1%) | -$34.59 M(+4.5%) |
| Dec 2020 | -$33.09 M | -$7.11 M(-11.5%) | -$33.09 M(+2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$8.03 M(+14.7%) | -$32.43 M(-3.5%) |
| June 2020 | - | -$7.00 M(-36.0%) | -$33.62 M(+1.0%) |
| Mar 2020 | - | -$10.94 M(+69.7%) | -$33.29 M(+7.9%) |
| Dec 2019 | -$30.84 M(+9.1%) | -$6.45 M(-30.1%) | -$30.84 M(+8.6%) |
| Sept 2019 | - | -$9.22 M(+38.2%) | -$28.41 M(+10.2%) |
| June 2019 | - | -$6.68 M(-21.4%) | -$25.79 M(-2.1%) |
| Mar 2019 | - | -$8.49 M(+111.4%) | -$26.33 M(-6.9%) |
| Dec 2018 | -$28.27 M(+111.8%) | -$4.02 M(-39.1%) | -$28.27 M(+8.2%) |
| Sept 2018 | - | -$6.60 M(-8.6%) | -$26.11 M(+11.6%) |
| June 2018 | - | -$7.22 M(-30.8%) | -$23.40 M(+18.4%) |
| Mar 2018 | - | -$10.43 M(+459.5%) | -$19.76 M(+48.0%) |
| Dec 2017 | -$13.35 M(+105.8%) | -$1.86 M(-52.0%) | -$13.35 M(+16.2%) |
| Sept 2017 | - | -$3.88 M(+8.6%) | -$11.48 M(+51.1%) |
| June 2017 | - | -$3.58 M(-11.0%) | -$7.60 M(+89.0%) |
| Mar 2017 | - | -$4.02 M | -$4.02 M |
| Dec 2016 | -$6.48 M(+168.9%) | - | - |
| Dec 2015 | -$2.41 M | - | - |
FAQ
- What is Cue Biopharma annual free cash flow?
- What is the all time high annual FCF for Cue Biopharma?
- What is Cue Biopharma annual FCF year-on-year change?
- What is Cue Biopharma quarterly free cash flow?
- What is the all time high quarterly FCF for Cue Biopharma?
- What is Cue Biopharma quarterly FCF year-on-year change?
- What is Cue Biopharma TTM free cash flow?
- What is the all time high TTM FCF for Cue Biopharma?
- What is Cue Biopharma TTM FCF year-on-year change?
What is Cue Biopharma annual free cash flow?
The current annual FCF of CUE is -$39.96 M
What is the all time high annual FCF for Cue Biopharma?
Cue Biopharma all-time high annual free cash flow is -$2.41 M
What is Cue Biopharma annual FCF year-on-year change?
Over the past year, CUE annual free cash flow has changed by +$2.02 M (+4.80%)
What is Cue Biopharma quarterly free cash flow?
The current quarterly FCF of CUE is -$7.53 M
What is the all time high quarterly FCF for Cue Biopharma?
Cue Biopharma all-time high quarterly free cash flow is -$1.86 M
What is Cue Biopharma quarterly FCF year-on-year change?
Over the past year, CUE quarterly free cash flow has changed by +$273.00 K (+3.50%)
What is Cue Biopharma TTM free cash flow?
The current TTM FCF of CUE is -$38.32 M
What is the all time high TTM FCF for Cue Biopharma?
Cue Biopharma all-time high TTM free cash flow is -$4.02 M
What is Cue Biopharma TTM FCF year-on-year change?
Over the past year, CUE TTM free cash flow has changed by +$1.20 M (+3.02%)